COST CM1407

Challenging organic synthesis inspired by nature - from natural products to drug discovery

Program:

COST

MC member:

RNDr. Horáková Ľubica PhD.

Duration:

 15.3.2015 - 14.3.2019

 

 

COST CA15135

MuTaLig - Multi-target paradigm for innovative ligand identification in the drug discovery process

Program:

COST

MC member:

RNDr. Májeková Magdaléna PhD.

Duration:

 4.12.2015 - 29.10.2019

 

GLUCOLIPOTOX - Targeting Molecular Pathways of Glucolipotoxicity by a Novel Carboxymethylated Mercaptotriazinoindole Inhibitor of Aldo-Keto Reductase AKR1B1 In Diabetes, Inflammation and Age-related Neurodegeneration

 

Program:

Bilateral SAS-Tübitak

MC member:

Ing. Štefek Milan, PhD.

Duration:

 1.5.2016-30.4.2019

 

National projects 

 

Pharmacological intervention in glucose-toxicity in type 2 diabetes

Program:

APVV

Project leader:

RNDr. Májeková Magdaléna PhD.

Duration:

01.07.2016 - 30.06.2020

 

Indole-1-acetic acid derivatives as aldose reductase inhibitors: structure – activity relationships

Program:

VEGA

Project leader:

Ing. Marta Šoltésová Prnová, PhD.

Duration:

1.1.2018 - 31.12.2021

 

Novel compounds in prevention and treatment of diseases caused by glucose toxicity

Program:

VEGA

Project leader:

RNDr. Májeková Magdaléna PhD.

Duration:

1.1.2018 - 31.12.2021

 

Modulation of calcium homeostasis in pancreatic ß-cells by flavonoids under conditions of endoplasmic reticulum stress

Program:

VEGA

Project leader:

RNDr. Lomenová (Viskupičová) Jana PhD.

Duration:

1.1.2016 - 31.12.2018